Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1882-1888
© 1995 American Heart Association, Inc.
Articles |
Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits
From the Department of Biochemistry (A.M., M.S., H.H., Y.-I.S., S.H.), the Second Department of Pathology (M.N., Y.R., K.T.), and the Department of Pediatrics (T.O.), Kumamoto University School of Medicine, and the Chemo-Sero-Therapeutic Research Institute (S.S., W.M., T. Takiue, F.M., T. Terano), Kumamoto, Japan.
Correspondence to Seikoh Horiuchi, MD, PhD, Department of Biochemistry, Kumamoto University School of Medicine, Honjo 2-2-1, Kumamoto 860, Japan.
Abstract The effects of intravenous injection of purified rabbit apoA-I on the progression of aortic atherosclerosis in cholesterol-fed rabbits were examined. In experiment 1, 28 rabbits were equally divided into groups A and B and fed a 0.5% cholesterol diet for 90 days. For the last 30 days, group B received 40 mg apoA-I every week. The fatty streak lesions in group B (23.9±15.6%) were significantly suppressed compared with those in group A (46.0±24.9%) (P<.05). In experiment 2, 33 rabbits were divided into four groups (8 or 9 rabbits per group) and fed a 0.5% cholesterol diet. Group A was killed on day 105, while groups B, C, and D were maintained for an additional 60 days on a normal diet, during which time groups C and D received 1 mg apoA-I every other day or 40 mg apoA-I every week, respectively. The lesions in group C (70.2±15.4%) and group D (65.7±20.0%) were significantly suppressed compared with those in group B (86.2±13.7%) (P<.05) but were not reduced to the level of group A (50.0±22.9%). Although apparent regression was not observed under these conditions, the present study provided the first evidence for the antiatherogenic effect of homologous apoA-I on the progression of atherosclerosis in cholesterol-fed rabbits.
Key Words: apoA-I • HDL • diet-induced atherosclerosis • cholesterol-fed rabbits • experimental atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  L. A. Morehouse, E. D. Sugarman, P.-A. Bourassa, T. M. Sand, F. Zimetti, F. Gao, G. H. Rothblat, and A. J. Milici Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits J. Lipid Res., June 1, 2007; 48(6): 1263 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Verna, C. Ganda, and M. B. Stemerman In Vivo Low-Density Lipoprotein Exposure Induces Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 Correlated With Activator Protein-1 Expression Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1344 - 1349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Duffy and D. J. Rader Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol Transport Circulation, February 28, 2006; 113(8): 1140 - 1150. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Ohashi, H. Mu, X. Wang, Q. Yao, and C. Chen Reverse cholesterol transport and cholesterol efflux in atherosclerosis QJM, December 1, 2005; 98(12): 845 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Oram and J. W. Heinecke ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease Physiol Rev, October 1, 2005; 85(4): 1343 - 1372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Gruen, M. R. Plummer, W. Zhang, K. A. Posey, M. Linton, S. Fazio, and A. H. Hasty Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I J. Lipid Res., September 1, 2005; 46(9): 2007 - 2014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Fazio and M. F. Linton Apolipoprotein AI as Therapy for Atherosclerosis: Does the Future of Preventive Cardiology Include Weekly Injections of the HDL Protein? Mol. Interv., December 1, 2003; 3(8): 436 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Rader High-Density Lipoproteins as an Emerging Therapeutic Target for Atherosclerosis JAMA, November 5, 2003; 290(17): 2322 - 2324. [Full Text] [PDF]
|
|
|
|
 |
|
 L. O. Martinez, B. Agerholm-Larsen, N. Wang, W. Chen, and A. R. Tall Phosphorylation of a Pest Sequence in ABCA1 Promotes Calpain Degradation and Is Reversed by ApoA-I J. Biol. Chem., September 26, 2003; 278(39): 37368 - 37374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zabalawi, S. Bhat, T. Loughlin, M. J. Thomas, E. Alexander, M. Cline, B. Bullock, M. Willingham, and M. G. Sorci-Thomas Induction of Fatal Inflammation in LDL Receptor and ApoA-I Double-Knockout Mice Fed Dietary Fat and Cholesterol Am. J. Pathol., September 1, 2003; 163(3): 1201 - 1213. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Macdonald, T. L. Terry, L. B. Agellon, P. N. Nation, and G. A. Francis Administration of Tyrosyl Radical-Oxidized HDL Inhibits the Development of Atherosclerosis in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1583 - 1588. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Belalcazar, A. Merched, B. Carr, K. Oka, K.-H. Chen, L. Pastore, A. Beaudet, and L. Chan Long-Term Stable Expression of Human Apolipoprotein A-I Mediated by Helper-Dependent Adenovirus Gene Transfer Inhibits Atherosclerosis Progression and Remodels Atherosclerotic Plaques in a Mouse Model of Familial Hypercholesterolemia Circulation, June 3, 2003; 107(21): 2726 - 2732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Parolini, G. Chiesa, Y. Zhu, T. Forte, S. Caligari, E. Gianazza, M. G. Sacco, C. R. Sirtori, and E. M. Rubin Targeted Replacement of Mouse Apolipoprotein A-I with Human ApoA-I or the Mutant ApoA-IMilano. EVIDENCE OF APOA-IM IMPAIRED HEPATIC SECRETION J. Biol. Chem., February 7, 2003; 278(7): 4740 - 4746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Forrester Prevention of Plaque Rupture: A New Paradigm of Therapy Ann Intern Med, November 19, 2002; 137(10): 823 - 833. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Chiesa, E. Monteggia, M. Marchesi, P. Lorenzon, M. Laucello, V. Lorusso, C. Di Mario, E. Karvouni, R. S. Newton, C. L. Bisgaier, et al. Recombinant Apolipoprotein A-IMilano Infusion Into Rabbit Carotid Artery Rapidly Removes Lipid From Fatty Streaks Circ. Res., May 17, 2002; 90(9): 974 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. X. Rong, J. Li, E. D. Reis, R. P. Choudhury, H. M. Dansky, V. I. Elmalem, J. T. Fallon, J. L. Breslow, and E. A. Fisher Elevating High-Density Lipoprotein Cholesterol in Apolipoprotein E-Deficient Mice Remodels Advanced Atherosclerotic Lesions by Decreasing Macrophage and Increasing Smooth Muscle Cell Content Circulation, November 13, 2001; 104(20): 2447 - 2452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Shah, S. Kaul, J. Nilsson, and B. Cercek Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I Circulation, November 6, 2001; 104(19): 2376 - 2383. [Full Text] [PDF]
|
|
|
|
|
|
Y. Stein and O. Stein Does Therapeutic Intervention Achieve Slowing of Progression or Bona Fide Regression of Atherosclerotic Lesions? Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 183 - 188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Desurmont, J.-M. Caillaud, F. Emmanuel, P. Benoit, J. C. Fruchart, G. Castro, D. Branellec, J.-M. Heard, and N. Duverger Complete Atherosclerosis Regression After Human ApoE Gene Transfer in ApoE-Deficient/Nude Mice Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 435 - 442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Dansky and E. A. Fisher High-Density Lipoprotein and Plaque Regression : The Good Cholesterol Gets Even Better Circulation, October 26, 1999; 100(17): 1762 - 1763. [Full Text] [PDF]
|
|
|
|
|
|
R. K. Tangirala, K. Tsukamoto, S. H. Chun, D. Usher, E. Pure, and D. J. Rader Regression of Atherosclerosis Induced by Liver-Directed Gene Transfer of Apolipoprotein A-I in Mice Circulation, October 26, 1999; 100(17): 1816 - 1822. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Deckert, G. Lizard, N. Duverger, A. Athias, V. Palleau, F. Emmanuel, M. Moisant, P. Gambert, C. Lallemant, and L. Lagrost Impairment of Endothelium-Dependent Arterial Relaxation By High-Fat Feeding in ApoE-Deficient Mice : Toward Normalization By Human ApoA-I Expression Circulation, September 14, 1999; 100(11): 1230 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Spady Reverse Cholesterol Transport and Atherosclerosis Regression Circulation, August 10, 1999; 100(6): 576 - 578. [Full Text] [PDF]
|
|
|
|
|
|
M. Eriksson, L. A. Carlson, T. A. Miettinen, and B. Angelin Stimulation of Fecal Steroid Excretion After Infusion of Recombinant Proapolipoprotein A-I : Potential Reverse Cholesterol Transport in Humans Circulation, August 10, 1999; 100(6): 594 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Han, J. Sasaki, A. Matsunaga, H. Hakamata, W. Huang, M. Ageta, T. Taguchi, T. Koga, M. Kugi, S. Horiuchi, et al. A Novel Mutant, ApoA-I Nichinan (Glu235->0), Is Associated With Low HDL Cholesterol Levels and Decreased Cholesterol Efflux From Cells Arterioscler. Thromb. Vasc. Biol., June 1, 1999; 19(6): 1447 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Boisvert, A. S. Black, and L. K. Curtiss ApoA1 Reduces Free Cholesterol Accumulation in Atherosclerotic Lesions of ApoE–Deficient Mice Transplanted With ApoE–Expressing Macrophages Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 525 - 530. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Benoit, F. Emmanuel, J. M. Caillaud, L. Bassinet, G. Castro, P. Gallix, J. C. Fruchart, D. Branellec, P. Denefle, and N. Duverger Somatic Gene Transfer of Human ApoA-I Inhibits Atherosclerosis Progression in Mouse Models Circulation, January 12, 1999; 99(1): 105 - 110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Miyazaki, N. Sakashita, O. Lee, K. Takahashi, S. Horiuchi, H. Hakamata, P. M. Morganelli, C. C. Y. Chang, and T.-Y. Chang Expression of ACAT-1 Protein in Human Atherosclerotic Lesions and Cultured Human Monocytes-Macrophages Arterioscler. Thromb. Vasc. Biol., October 1, 1998; 18(10): 1568 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Shah, J. Nilsson, S. Kaul, M. C. Fishbein, H. Ageland, A. Hamsten, J. Johansson, F. Karpe, and B. Cercek Effects of Recombinant Apolipoprotein A-IMilano on Aortic Atherosclerosis in Apolipoprotein E–Deficient Mice Circulation, March 3, 1998; 97(8): 780 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.N. Nanjee, J.R. Crouse, J.M. King, R. Hovorka, S.E. Rees, E.R. Carson, J.-J. Morgenthaler, P. Lerch, and N.E. Miller Effects of Intravenous Infusion of Lipid-Free Apo A-I in Humans Arterioscler. Thromb. Vasc. Biol., September 1, 1996; 16(9): 1203 - 1214. [Abstract] [Full Text]
|
|